- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Study: Little Research on Overuse of Healthcare in U.S.
Most studies measure overuse of antibiotics for upper respiratory infections, coronary artery bypass grafting, coronary angiography and carotid endarterectomy, said the authors, who reviewed data from more than 170 articles on the use of tests, procedures and medications. Research has been mostly confined to those 4 areas because there are clear parameters for judging appropriateness of care, they added.
“The limited overuse literature is understandable given the challenges of developing standards to measure overuse,” the authors wrote.
The authors emphasized the need for better guidelines on a wider range of healthcare interventions as a way to boost research on overuse, particularly in areas such as preventive diagnostic services.
Read more:http://tinyurl.com/7tce5rm
Despite concerns about the high cost and inefficiency associated with the overuse of healthcare, research is limited and often addresses only a few medical interventions, according to an article published in the Archives of Internal Medicine.Source: Modern Healthcare
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
